期刊文献+

左心辅助装置的临床应用 被引量:1

Clinical Application for Left Ventricular Assistant Device (TCI HeartMate 1000IP)
下载PDF
导出
摘要 目的:研究左心辅助装置(LVAD)TCI HeartMate 1000 IP对终末期心脏病人的救治作用和并发症。方法:总结9例LVAD植入资料。原发病为:扩张型心肌病4例,冠心病4例,先天性主动脉瓣狭窄合并冠心病1例。术前平均射血分数为0.145±0.04。结果:LVAD植入后,心排量指数由术前(1.76±0.50)L·m^2·min^(-1)升至(3.34±0.96)L·m^2·min^(-1)(P<0.05),肺动脉毛细血管嵌顿压由(28.6±4.5)mmHg降至(12.9±4.9)mmHg(P<0.05)。在ICU的天数为:(17.3±15.5)天。LVAD支持时间为平均(66.9±50.9)天。有5例过渡至心脏移植并痊愈出院。死亡4例:3例死于右心衰和呼吸衰竭,1例死于全身衰竭。主要并发症:(1)出血;(2)右心衰;(3)脑栓塞;(4)感染。结论:TCI Heart Mate 1000 IP能为终末期心脏病人提供可靠的血流动力学支持,过渡至心脏移植。 To study the effect of left ventricular assistant device (LVAD) , TCI Heart Mate 1000IP in rescue the terminal cardiac patients and its complications. Methods: The data for 9 cases of LVAD implantation were summarized. The primary heart diseases were: 4 cases of dilated cardiomyopathy. 4 coronary artery disease (CAD) and 1 congenital aortic stenosis combined with CAD. The ejection fraction (EF) before operation was 0. 145 ±0. 04. Results: After implantation of LVAD, cardiac output index (CI) increased from (1.76±0.50) Lm2min-1to (3.34±0.96) L-m2-min-J(P<0.05). Pulmonary arterial wedge pressure decreased from (28.6 ± 4.5) mmHg to (12.9 ±4. 9) mmHg (P<0.05). The mean 1CU stay were (17.3 ± 15.5) days. The mean support time for LVAD were (66.9 ±50.9) days. Among them 5 cases went over to heart transplantation and were discharged. Four patients died: 3 due to the right heart and respiratory failure and 1 due to the multiple organ failure. The main comlications were bleeding, right heart failure, neu-rocomplicaion and infection. Conclusions: TCI HeatrMate 1000IP could offer hemodynamic support for the terminal heart patients and let the patients go over to heart transplantation.
出处 《国外医学(心血管疾病分册)》 2002年第6期354-357,共4页
关键词 左心辅助装置 临床应用 HeartMate 存活率 并发症 LVAD HeartMate Survival rate Complications
  • 相关文献

参考文献8

  • 1[1]El Banayosy A, Fey O, Sarnowski P, et al. Midterm follow-up of patients discharged from hospital under left ventricular assistance. J Heart Lung Transplant, 2001; 20(1):53~58
  • 2[2]McCarthy PM. HeartMate implantable left ventricular assist device: bridge to transplantation and future applications. Ann Thorac Surg, 1995; 59(2 Suppl): S46~S51
  • 3[3]Bank AJ, Mir SH, Nguyen DQ, et al. Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation. Ann Thorac Surg, 2000; 69(5): 1369~1374
  • 4[4]Hsu RB, Chu SH, Chien CY, HeartMate left ventricular assist device for long-term circulatory support. J Formos Med Assoc, 2000; 99(4): 336~340
  • 5[5]Koul B, Solem JO, Steen S, et al. HeartMate left ventricular assist device as bridge to heart transplantation. Ann Thorac Surg, 1998; 65(6): 1625~1630
  • 6[6]Reilly MP, Wiegers SE, Cucchiara AJ, et al. Frequency, risk factors, and clinical outcomes of left ventricular assistdevice-associated ventricular thrombus. Am J Cardiol, 2000; 15; 86(10): 1156~1159
  • 7[7]Kaplon RJ, Gillinov AM, Smedira NG, et al. Vitamin K reduces bleeding in left ventricular assist device recipients. J Heart Lung Transplant, 1999; 18(4): 346~350
  • 8[8]Fukamachi K, McCarthy PM, Smedira NG, et al. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg, 1999; 68(6): 2181~2184

同被引文献22

  • 1臧旺福,夏求明.应进一步提高我国心脏移植的治疗水平[J].中华医学杂志,2004,84(19):1585-1586. 被引量:11
  • 2[1]Taylor DO,Edwards LB,Boucek MM,et al.Registry of the international society for heart and lung transplantation:twenty-second official adult heart transplant report-2005[J].J Heart Lung Transplant,2005,24(8):945-982.
  • 3[2]Trulock EP,Edwards LB,Taylor DO,et al.The registry of the international society for heart and lung transplantation:twenty-first official adult lung and heart-lung transplant report-2004[J].J Heart Lung Transplant,2004,23(7):804-815.
  • 4田海,臧旺福,夏求明.终末期心脏病治疗进展[J].JTransplant Dec,2003,1(1):13-16.
  • 5[5]Reilly MP,Wicgers SE,Cucchiara AJ,et al.Frequency,risk factors.and clinical outcomes of left ventricular assist device-associated ventrieular thrombus[J].Am J Cardiol,2000,86(10):1156-1159,A10.
  • 6[6]Eckhauser AE,Melvin WV,Sharp KW.Management of general surgical problems in patients with left ventricular assist devices[J].Am Surg,2006,72(2);158-161.
  • 7[8]Syracuse PL,Yager C,Smedira N,et al.Savage RM immediate post-LVAD implant support;two approaches[J].J Extra Corpor Technol,2005,37(4):373-376.
  • 8[9]Kar B,Delgado RM 3rd,Frazier OH,et al.The effect of LVAD aortic outflow-graft placement on hemodynamics and flow:Implantation technique and computer flow modeling[J].Tex Heart Inst J,2005,32(3):294-298.
  • 9[10]Stainback RF,Croitoru M,Hernandez A,et al.Echocardiographic evaluation of the Jarvik 2000 axial-flow LVAD[J].Tex Heart Inst J,2005,32(3):263-270.
  • 10[11]BIanche C,Frota-Filho JD,Trento A,et al.Technical considerations for partial left ventriculectomy(Batista operation)[J].J Cardiovasc Surg(Torino),1998,39(6)829-832.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部